CanSino Biologics Inc. (HKG:6185)

CanSino Biologics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,411	11,610	12,491	27,690	66,111	74,412
Market Cap Growth	9.08%	-7.06%	-54.89%	-58.12%	-11.15%	466.94%
Enterprise Value	11,918	10,302	10,588	23,868	58,920	68,404
Last Close Price	38.30	31.50	23.55	66.75	177.89	174.24
PE Ratio	-	-	-	-	28.13	-
Forward PE	50.19	-	-	-	11.16	25.30
PS Ratio	12.63	12.89	31.75	23.68	12.53	2517.38
PB Ratio	2.49	2.22	2.14	3.38	6.30	10.32
P/TBV Ratio	2.59	2.28	2.21	3.75	6.89	10.38
P/FCF Ratio	-	-	-	-	63.60	-
P/OCF Ratio	79.88	-	-	-	26.27	-
EV/Sales Ratio	11.22	11.44	26.92	20.41	11.16	2314.14
EV/EBITDA Ratio	-	-	-	-	25.96	-
EV/EBIT Ratio	-	-	-	-	26.91	-
EV/FCF Ratio	-69.63	-	-	-	56.68	-
Debt / Equity Ratio	0.29	0.41	0.51	0.37	0.16	0.02
Debt / EBITDA Ratio	-	-	-	-	0.74	-
Debt / FCF Ratio	-	-	-	-	1.62	-
Asset Turnover	0.13	0.10	0.03	0.09	0.46	0.01
Inventory Turnover	0.71	0.83	1.55	1.57	2.48	0.16
Quick Ratio	3.24	2.38	1.86	2.33	2.78	12.54
Current Ratio	3.62	2.54	2.02	2.64	3.25	13.24
Return on Equity (ROE)	-2.84%	-7.52%	-31.40%	-12.22%	26.09%	-10.52%
Return on Assets (ROA)	-1.87%	-2.74%	-10.36%	-8.03%	11.97%	-7.58%
Return on Capital (ROIC)	-2.11%	-3.18%	-12.01%	-9.43%	13.82%	-8.24%
Return on Capital Employed (ROCE)	-3.70%	-6.00%	-25.50%	-17.50%	19.80%	-8.20%
Earnings Yield	-1.16%	-3.47%	-13.08%	-3.71%	3.55%	-0.63%
FCF Yield	-1.28%	-5.73%	-13.39%	-11.95%	1.57%	-1.02%
Dividend Yield	-	-	-	-	0.55%	-
Payout Ratio	-	-	-	-	0.74%	-
Buyback Yield / Dilution	1.66%	-0.38%	0.17%	0.08%	-7.26%	-13.46%
Total Shareholder Return	1.66%	-0.38%	0.17%	0.08%	-6.70%	-13.46%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.